Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRUKER CORPORATION

(BRKR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bruker : UBS Adjusts Bruker's Price Target to $80 From $74, Citing 'Durable' Growth Drivers; Neutral Rating Kept

06/18/2021 | 10:15am EDT


ę MT Newswires 2021
All news about BRUKER CORPORATION
07/21BRUKER : Announces Date and Time of Second Quarter 2021 Earnings Release and Web..
BU
07/13BRUKER : Release of NMR Honey-Profiling 3-0 Module Further Extends Sophisticated..
PU
07/09BRUKER : Announces New Microbiology Products and Workflows for Microbial Identif..
PU
07/06BRUKER : New Bruker NMR Life Science Research Solutions Enable Functional Struct..
PU
07/05BRUKER : Richard R. Ernst Prize Winners in Magnetic Resonance
PU
07/05BRUKER : Honors Legacy of Swiss Nobel Laureate in Chemistry ETH Professor Richar..
PU
06/25BRUKER CORPORATION(NASDAQGS : BRKR) dropped from Russell 3000 Value Index
CI
06/25BRUKER CORPORATION(NASDAQGS : BRKR) dropped from Russell 2500 Value Index
CI
06/25BRUKER CORPORATION(NASDAQGS : BRKR) dropped from Russell 1000 Value Index
CI
06/25BRUKER CORPORATION(NASDAQGS : BRKR) dropped from Russell Small Cap Comp Value In..
CI
More news
Financials (USD)
Sales 2021 2 343 M - -
Net income 2021 254 M - -
Net Debt 2021 136 M - -
P/E ratio 2021 48,0x
Yield 2021 0,20%
Capitalization 12 252 M 12 252 M -
EV / Sales 2021 5,29x
EV / Sales 2022 4,92x
Nbr of Employees 7 400
Free-Float 58,6%
Chart BRUKER CORPORATION
Duration : Period :
Bruker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRUKER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 80,86 $
Average target price 74,27 $
Spread / Average Target -8,15%
EPS Revisions
Managers and Directors
Frank H. Laukien Chairman, President & Chief Executive Officer
Gerald N. Herman Chief Financial Officer & Vice President
William Alderman Linton Lead Independent Director
Richard A. Packer Independent Director
Hermann Fritz Requardt Independent Director
Sector and Competitors